Real-time algorithm-driven ventilation feedback to improve lung-protective ventilation in patients with ARDS (REALVENT-study): study protocol for a multicentre randomised controlled trial.
Summary
This is the protocol for a multicentre, open-label RCT (n=208) testing a cloud-based, real-time respiratory mechanics feedback platform aiming to increase adherence to lung-protective ventilation targets in ARDS over the first 72 hours. Primary outcome is the lung-protective ventilation achievement rate; secondary outcomes include ventilator-free days, ICU length of stay, complications, biomarkers and safety endpoints.
Key Findings
- Protocol for a multicentre RCT (n=208) comparing standard monitoring vs cloud-based real-time feedback in ARDS.
- Primary outcome: lung-protective ventilation achievement rate over first 72 hours defined by VT, driving pressure, plateau pressure, and mechanical power thresholds.
- Secondary outcomes include ventilator-free days at day 28, ICU LOS, complications, inflammatory biomarkers, clinician satisfaction, and predefined safety endpoints.
Clinical Implications
Potential to increase adherence to low VT/driving pressure/limited mechanical power strategies in the early ARDS period; could be adopted as a decision-support tool in ICUs pending positive trial results.
Why It Matters
If successful, the trial could provide the first multicentre RCT evidence that continuous algorithmic feedback increases delivery of lung-protective ventilation and may standardize bedside adjustments across centers.
Limitations
- Open-label design may introduce performance bias despite objective endpoints.
- Conducted in mainland China ICUs; generalizability to other healthcare systems and device ecosystems may require validation.
Future Directions
If efficacy is demonstrated, next steps include implementation studies across diverse ICU settings, cost-effectiveness analysis, and integration with closed-loop ventilation systems.
Study Information
- Study Type
- RCT
- Research Domain
- Treatment/Implementation
- Evidence Level
- I - Randomized controlled trial protocol designed to generate highest-level clinical evidence for an intervention
- Study Design
- OTHER